Table 2.
Overall survival data
| Ref. | Year |
Median OS (mo) |
5 Year OS (%) |
OS Hazard ratio |
|||||||||
| L | R | Rectum | P value | L | R | Rectum | P value | L | R | Rectum | P value | ||
| Zhou et al[27] | 2017 | 35 | 33 | 32 | 27.5 | 23.1 | 23 | 0.85 | 1 | 1.02 | |||
| Zhang et al[30] | 2017 | 22 | 12 | 0.012a | |||||||||
| 14 | 10 | ||||||||||||
| Makowiec et al[37] | 2018 | 41 | 46 | ||||||||||
| Chafai et al[29] | 2005 | 22.5 | 9.9 | < 0.001a | 1 | 1.68 | < 0.001a | ||||||
| Rougier et al[15] | 1995 | 8.2 | 4.5 | 7.6 | < 0.001a | ||||||||
| 6.8 | 3.8 | 6.6 | < 0.001a | ||||||||||
| Wang et al[38] | 2018 | 38.3 | 46.5 | 1 | 1.08 | ||||||||
| Gu et al[28] | 2018 | 40.3 | 29.4 | 0.042a | 1 | 6.2 | < 0.001a | ||||||
| Gasser et al[12] | 2019 | 55.5 | 33.5 | 58.2 | 1 | 1.53 | 0.029a | ||||||
| de Haas et al[24] | 2010 | 54 | 36 | 48 | 0.001a | 1 | 1.5 | ||||||
| Marques et al[11] | 2018 | 1 | 2.1 | ||||||||||
| Russolillo et al[21] | 2019 | 63.3 | 35.7 | 0.002a | 0.82 | 1 | < 0.001a | ||||||
| Umeda et al[34] | 2013 | 1.24 | 1 | 1.62 | |||||||||
| Zheng et al[31] | 2018 | 29.5 | 21.9 | < 0.001a | 0.5 | 1 | < 0.001a | ||||||
| Mavros et al[39] | 2013 | 1 | 1.09 | ||||||||||
| Viganò et al[20] | 2014 | 41.3 | 58.3 | 47.4 | 43.1 | 44.7 | 41.3 | ||||||
| Connor et al[40] | 2016 | 1 | 2.4 | 0.0321a | |||||||||
| Eefsen et al[41] | 2015 | 0.63 | 1 | 0.57 | 0.045a | ||||||||
| Schirripa et al[33] | 2015 | 57.3 | 35.5 | 61.1 | 0.017a | 1 | 1.59 | 0.95 | 0.017a | ||||
| Loosen et al[42] | 2018 | 1 | 2.32 | ||||||||||
| Amikura et al[32] | 2018 | 56.1 | 48.4 | 1 | 1.287 | ||||||||
| Yamashita et al[26] | 2018 | 52 | 32 | < 0.0001a | 1 | 2.04 | < 0.0001a | ||||||
| 78 | 55 | 0.003a | 1 | 1.9 | 0.0009a | ||||||||
| Dulundu et al[19] | 2017 | 30.43 | 46.38 | 40.86 | 52.5 | 54.1 | 59 | ||||||
| Creasy et al[9] | 2016 | 62.4 | 43.2 | 50.4 | 38.5 | 0.028a | 1 | 1.22 | 0.028a | ||||
| Sasaki et al[23] | 2016 | 55.3 | 44.1 | 0.033a | 53.7 | 41.5 | 0.76 | 1 | 0.033a | ||||
| Palkovics et al[43] | 2018 | 39 | 36 | 40 | |||||||||
| Dupré et al[8] | 2018 | 45.3 | 34.6 | 0.035a | 37.5 | 25.4 | 0.010a | 1 | 1.429 | 0.036a | |||
| Shigematsu et al[44] | 2018 | 0.67 | 1 | 0.63 | |||||||||
| Rhu et al[45] | 2017 | 0.862 | 1 | ||||||||||
| Wang et al[46] | 2017 | 0.75 | 1 | ||||||||||
| Norén et al[18] | 2015 | 61 | 57 | 48 | 0.02a | 45.8 | 44.5 | 42.6 | 0.02a | 0.75 | 1 | 0.73 | < 0.001a |
| Cremolini et al[16] | 2018 | 0.96 | 1 | ||||||||||
| McCracken et al[48] | 2019 | 75.6 | 54 | < 0.001a | 1 | 1.6 | 0.001a | ||||||
| McVey et al[49] | 2019 | 43 | 44.2 | 1.108 | 1 | ||||||||
| 79.4 | 64.6 | 0.037a | 0.629 | 0.788 | 0.024a | ||||||||
| Imai et al[35] | 2019 | 55.5 | 52.3 | 1 | 3.44 | 0.021a | |||||||
| Koch et al[36] | 2018 | 0.66 | 1 | ||||||||||
| Liao et al[10] | 2018 | 75.2 | 61.7 | 0.005a | |||||||||
| Adam et al[50] | 2011 | 31 | 0 | 36 | 0.003a | 1 | 2.2 | 0.003a | |||||
| Wang et al[17] | 2019 | 40.1 | 24.6 | < 0.001a | 1 | 1.75 | < 0.001a | ||||||
Zhang et al[30]: Top group: Overall population, bottom row: Patients who did not receive chemotherapy; Rougier et al[15]: Resection subgroup data presented in row above non-resection subgroup data; Yamashita et al[26]: Data for study set displayed above data for validation set; McVey et al[49]: R1 Resection data displayed over R0 Resection data. OS: Overall Survival.
P < 0.05. L: Left; R: Right.